Q2 2025 · 13F-HR
a16z Capital Management, L.L.C.holdings as filed
Filed 2025-08-14 · accession 0001415889-25-021833
$312.9M
Reported value
10
Positions
2025-06-30
Period end
The Brief · a16z Capital Management, L.L.C. · Q2 2025
AI · grounded in 13F
a16z Capital Management, L.L.C. established a new position in RVMD valued at $101.1M. The fund also initiated stakes in OMDA for $84.4M and XYZ for $69.1M. Other new additions include MAZE, BIOA, and NAUT.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $101.1M | 32.3% | 2,748,523 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $84.4M | 27.0% | 4,614,574 | Common | SOLE |
| 852234103 | XYZ | BLOCK INC | $69.1M | 22.1% | 1,016,697 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $20.9M | 6.67% | 1,702,225 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $13.4M | 4.27% | 3,233,170 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $12.8M | 4.09% | 17,653,917 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $3.6M | 1.16% | 2,862,500 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $3.3M | 1.06% | 6,200,821 | Common | SOLE |
| 13463J101 | CAMP | CAMP4 THERAPEUTICS CORP | $3.1M | 0.98% | 2,125,339 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $1.2M | 0.39% | 108,568 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.